TS gene expression was significantly increased in clA and clC relative to parental cells (Fig. 5d), suggesting that this mechanism may be responsible for resistance, in keeping with published literature demonstrating that TS overexpression is a common mechanism for resistance to pemetrexed therapy in NSCLC [16]. Here, TYMS is linked to non-small cell lung carcinoma.